Pages

Tuesday, March 28, 2017

FDA approves 'game-changer' drug for serious cases of eczema

... list price of $37,000 per year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug. The drug is an antibody that patients inject just under the skin every two weeks. It binds to ...
http://ift.tt/2nJp7dW

No comments:

Post a Comment